Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.
about
Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer.The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding starCarcinogenesis in prostate cancer: The role of long non-coding RNAsDysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients
P2860
Q33798405-8F9DD16C-CBDF-48F4-BCF7-C1741475A9A3Q37724539-497D11D4-615A-47F9-BBCB-3518DE722EE3Q38758656-7B3C032B-A6C4-4E9A-A6F9-4C85A0B85043Q41339824-7FB86A28-2B42-4ECD-B48C-A33C72133AAEQ41612462-A93CD6BC-56C3-4930-8CFF-7B0A5AB49470Q42353504-E4650247-F537-41EF-8093-F71A4EE4B296Q49213554-88E153CB-9674-4C79-B11B-B168A60A1374Q49486523-8E8511D7-1261-441A-97F4-66DFEB073D0CQ55356724-F3CBFE36-6D6C-4795-9A71-6E657FBD7F97Q57109348-3CFD9C1C-A1E7-4EE1-9B42-71C3D6D05176Q57114753-0C473B59-FE64-48A9-AEBE-C42A564EBEACQ58612336-EC5CB786-689B-4930-93AD-C07CE073F1EB
P2860
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@en
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@nl
type
label
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@en
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@nl
prefLabel
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@en
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@nl
P2093
P50
P1433
P1476
Multi-institutional Analysis S ...... r Outcomes in Prostate Cancer.
@en
P2093
Abdallah M Eteleeb
Christopher A Maher
Emily B Rozycki
Ismael A Vergara
Jeffrey M Arbeit
Mohammed Alshalalfa
Nicole M White
Robert Jeffrey Karnes
P304
P356
10.1016/J.EURURO.2016.07.012
P407
P577
2016-07-22T00:00:00Z